These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Study of immunosuppressive acidic protein (IAP) in patients with renal cell cancer].
    Author: Shibayama T, Nakazono M, Koyama Y, Deguchi N, Baba S, Jitsukawa S, Murai M, Tazaki H.
    Journal: Gan No Rinsho; 1984 May; 30(5):481-6. PubMed ID: 6727048.
    Abstract:
    We evaluated immunosuppressive acidic protein (IAP) as a tumor marker in renal cell cancer. The study was comprised of patients with renal cell cancer (6 stage A, 3 stage C, 11 stage D, 7 recurrences). The IAP positive rate of renal cell cancer was 84%, the mean was 937.5 +/- 442.1 ug/ml. The positive rate is statistically higher than in other malignant and benign urological diseases. The IAP positive rate tended to increase with cancer stage. IAP may represent a tumor marker in renal cell cancer.
    [Abstract] [Full Text] [Related] [New Search]